内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Aziz Kabeer, 董事. Director active across 1 company, notably AN2 Therapeutics, Inc.. In total, 19 filings have been published. Split: 0 buy · 10 sells. Total volume traded: €3.2m. History available since 6 June 2022. The latest transaction was disclosed on 10 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Aziz Kabeer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
2,852 股0Common StockSEC:0001193125-26-301167:0
3,775 股0Common StockSEC:0001193125-26-151632:0
11,560 股0Common StockSEC:0001193125-26-013041:0
10,367 股0Common StockSEC:0001193125-25-238983:0
11,875 股0Common StockSEC:0000950170-25-095408:0
9,705 股0Common StockSEC:0000950170-25-053367:0
8,972 股0Common StockSEC:0000950170-24-139800:0
84,093 股@ US$19.6542.1% 占其流量Common StockSEC:0000950170-24-005515:0
1,522 股@ US$16.1460.6% 占其流量Common StockSEC:0000950170-23-064609:0
83,337 股@ US$16.2835.8% 占其流量Common StockSEC:0000950170-23-051733:0
15,764 股@ US$16.286.8% 占其流量Common StockSEC:0000950170-23-051733:1
4,770 股@ US$16.072.0% 占其流量Common StockSEC:0000950170-23-051733:2
902 股@ US$16.070.4% 占其流量Common StockSEC:0000950170-23-051733:3
707 股@ US$16.072.5% 占其流量Common StockSEC:0000950170-23-050851:0
336 股@ US$16.000.1% 占其流量Common StockSEC:0000950170-23-048436:0
3,164 股@ US$16.021.3% 占其流量Common StockSEC:0000950170-23-047311:0
336 股@ US$16.000.1% 占其流量Common StockSEC:0000950170-23-044593:0
26,511 股@ US$15.000.23% mcap100.0% 占其流量Common StockSEC:0000899243-22-024054:0
1,651,636 股Common StockSEC:0000899243-22-012988:0
About Aziz Kabeer
Aziz Kabeer is Administrateur at AN2 Therapeutics, Inc. (XNAS). He has 19 filings in total, and across the recent sample of 19 filings, the activity is mainly sales, with EUR 0 in buys and EUR 3215076 in sells between 2022-03-31 and 2026-07-10.